Health Score

0 Fair

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 69 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact69 DOIs

Add abstracts to 47 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact47 DOIs

Deposit reference lists for 1 record

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 70 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Metabolic and alcohol-associated liver disease (MetALD): a r… (10.1038/s44355-024-00014-8)	Abstract ORCID	80.64	40
2	Pathophysiology, noninvasive diagnostics and emerging person… (10.1038/s44355-025-00030-2)	Abstract ORCID	71.57	26
3	Gut microbiota and dynamics of ammonia metabolism in liver d… (10.1038/s44355-024-00011-x)	Abstract ORCID	69.90	24
4	Resmetirom and GLP-1 agonists for MASH: complementary rather… (10.1038/s44355-024-00004-w)	Abstract ORCID	69.01	23
5	Reviewing MAESTRO-NASH and the implications for hepatology a… (10.1038/s44355-024-00017-5)	Abstract ORCID	63.94	18
6	Improving immunotherapy for the treatment of hepatocellular… (10.1038/s44355-025-00018-y)	Abstract ORCID	62.76	17
7	MicroRNA in intestinal tight junction regulation (10.1038/s44355-025-00022-2)	Abstract ORCID	57.31	13
8	Distinct age-related characteristics in patients with irrita… (10.1038/s44355-024-00010-y)	Abstract ORCID	42.25	6
9	Pharmaceutical and clinical implications of proton pump inhi… (10.1038/s44355-024-00012-w)	Abstract ORCID	42.25	6
10	Unlocking therapeutic potential of amlexanox in MASH with in… (10.1038/s44355-024-00015-7)	Abstract ORCID	42.25	6
11	Steatotic liver disease is a marker of multimorbidity, not u… (10.1038/s44355-025-00024-0)	Abstract ORCID	42.25	6
12	Decoding the molecular and genomic landscape of hepatocellul… (10.1038/s44355-025-00038-8)	Abstract ORCID	42.25	6
13	Stiffness-induced modulation of ERG transcription factor in… (10.1038/s44355-024-00007-7)	Abstract ORCID	38.91	5
14	Association of metabolic abnormalities and the risk of hepat… (10.1038/s44355-025-00025-z)	Abstract ORCID	38.91	5
15	Artificial Intelligence-based agents in chronic liver diseas… (10.1038/s44355-025-00049-5)	Abstract ORCID	38.91	5
16	Addressing global variation and systemic inequities in acces… (10.1038/s44355-025-00045-9)	Abstract ORCID	34.95	4
17	Role of VEGFA in type 2 diabetes mellitus rats subjected to… (10.1038/s44355-024-00013-9)	Abstract ORCID	30.10	3
18	Clostridioides difficile infection induces a pro-inflammator… (10.1038/s44355-024-00016-6)	Abstract ORCID	30.10	3
19	The burden of digestive diseases in Asian countries and terr… (10.1038/s44355-025-00019-x)	Abstract ORCID	30.10	3
20	The Microleaks study: 16S community profile and metagenomic… (10.1038/s44355-024-00006-8)	ORCID	28.65	13
21	Closing the gap in HCV care: strategic collaboration between… (10.1038/s44355-025-00028-w)	Abstract ORCID	23.86	2
22	Exploring the trimethylamine pathway in advanced chronic liv… (10.1038/s44355-025-00029-9)	Abstract ORCID	23.86	2
23	Comparative analysis of dietary fiber impact on bile acid me… (10.1038/s44355-025-00041-z)	ORCID	23.86	8
24	Endocrine disruptors reprogram hepatic metabolic and immune… (10.1038/s44355-026-00060-4)	Abstract ORCID	23.86	2
25	Scores to predict steatotic liver disease – correlates and o… (10.1038/s44355-025-00021-3)	ORCID	21.13	6
26	Surgical optomics: a new science towards surgical precision (10.1038/s44355-025-00035-x)	ORCID	21.13	6
27	Accelerometer-based sedentary time and physical activity wit… (10.1038/s44355-024-00002-y)	ORCID	19.45	5
28	Impact of oxidized low-density lipoprotein on rat liver sinu… (10.1038/s44355-024-00009-5)	ORCID	19.45	5
29	Patients with ulcerative colitis who have normalized histolo… (10.1038/s44355-024-00005-9)	ORCID	17.47	4
30	The polyphenol-rich plant extract Totum-448 decreases hepati… (10.1038/s44355-025-00033-z)	ORCID	17.47	4
31	Optimizing the liver transplant candidate (10.1038/s44355-024-00003-x)	ORCID	15.05	3
32	The role of Neuregulin-1 in steatotic and non-steatotic live… (10.1038/s44355-024-00008-6)	Abstract ORCID	15.05	1
33	Statins exposure and adverse events in participants with chr… (10.1038/s44355-025-00020-4)	Abstract ORCID	15.05	1
34	Pyrimidinetrione benzodioxol ameliorates MAFLD-induced liver… (10.1038/s44355-025-00023-1)	Abstract ORCID	15.05	1
35	Lithocholic acid facilitates release of angiocrine factors b… (10.1038/s44355-025-00034-y)	Abstract ORCID	15.05	1
36	Silencing of S100A11 attenuates murine metabolic dysfunction… (10.1038/s44355-025-00044-w)	Abstract ORCID	15.05	1
37	Add-on to current guidelines for monitoring of SBS patients… (10.1038/s44355-025-00047-7)	Abstract ORCID	15.05	1
38	Limited duodenal immune activation in functional dyspepsia i… (10.1038/s44355-025-00050-y)	Abstract ORCID	15.05	1
39	Mechanisms of orphan nuclear receptor Nur77 in liver health,… (10.1038/s44355-025-00037-9)	ORCID	11.93	2
40	PARPs in liver diseases (10.1038/s44355-025-00043-x)	ORCID	7.53	1
41	Optimising the induction of inflammation within preterm infa… (10.1038/s44355-026-00054-2)	ORCID	7.53	1
42	Alterations of the peptidomic composition of peripheral plas… (10.1038/s44355-024-00001-z)	ORCID	0.00	0
43	A retrospective study on colorectal lesion risk assessment i… (10.1038/s44355-025-00026-y)	Abstract ORCID	0.00	0
44	Specific clinicopathologic findings are associated with the… (10.1038/s44355-025-00027-x)	Abstract ORCID	0.00	0
45	Automated digital analysis of propagated contractions record… (10.1038/s44355-025-00031-1)	Abstract ORCID	0.00	0
46	Rearrangement of the liver ubiquitome and NEDDylome in metab… (10.1038/s44355-025-00032-0)	Abstract ORCID	0.00	0
47	Validation of novel irritable bowel syndrome subgroups based… (10.1038/s44355-025-00036-w)	ORCID	0.00	0
48	Assessing liver-brain-muscle axis fatigability: five-run Str… (10.1038/s44355-025-00039-7)	Abstract ORCID	0.00	0
49	Integrative multi-omics and causal inference unveil novel th… (10.1038/s44355-025-00040-0)	ORCID	0.00	0
50	Adrenergic G protein-coupled receptors in liver physiology a… (10.1038/s44355-025-00042-y)	Abstract ORCID	0.00	0